Renaissance Technologies’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,074
Closed -$334K 4604
2022
Q2
$334K Sell
6,074
-86,400
-93% -$4.75M ﹤0.01% 3395
2022
Q1
$2.96M Sell
92,474
-18,561
-17% -$595K ﹤0.01% 1930
2021
Q4
$2.41M Buy
111,035
+5,761
+5% +$125K ﹤0.01% 1993
2021
Q3
$2.31M Sell
105,274
-900
-0.8% -$19.7K ﹤0.01% 1976
2021
Q2
$2.07M Sell
106,174
-1,300
-1% -$25.3K ﹤0.01% 2239
2021
Q1
$1.85M Buy
107,474
+700
+0.7% +$12.1K ﹤0.01% 2280
2020
Q4
$1.71M Buy
106,774
+5,700
+6% +$91.4K ﹤0.01% 2215
2020
Q3
$1.08M Buy
101,074
+6,600
+7% +$70.4K ﹤0.01% 2480
2020
Q2
$1.14M Buy
94,474
+9,500
+11% +$115K ﹤0.01% 2476
2020
Q1
$834K Sell
84,974
-1,438
-2% -$14.1K ﹤0.01% 2515
2019
Q4
$1.18M Buy
86,412
+20,618
+31% +$282K ﹤0.01% 2552
2019
Q3
$1.03M Buy
65,794
+7,978
+14% +$125K ﹤0.01% 2584
2019
Q2
$1.3M Buy
57,816
+10,433
+22% +$234K ﹤0.01% 2569
2019
Q1
$3.24M Buy
47,383
+2,163
+5% +$148K ﹤0.01% 2068
2018
Q4
$2.39M Sell
45,220
-11,086
-20% -$585K ﹤0.01% 2133
2018
Q3
$3.83M Buy
56,306
+12,133
+27% +$825K ﹤0.01% 1962
2018
Q2
$5.23M Sell
44,173
-1,660
-4% -$197K 0.01% 1765
2018
Q1
$3.8M Buy
45,833
+27,365
+148% +$2.27M ﹤0.01% 1997
2017
Q4
$2.76M Buy
18,468
+10,358
+128% +$1.55M ﹤0.01% 2154
2017
Q3
$503K Buy
8,110
+5,297
+188% +$329K ﹤0.01% 2784
2017
Q2
$132K Buy
+2,813
New +$132K ﹤0.01% 3052
2016
Q4
Sell
-5,645
Closed -$411K 3544
2016
Q3
$411K Buy
+5,645
New +$411K ﹤0.01% 2864
2016
Q2
Sell
-1,133
Closed -$305K 3570
2016
Q1
$305K Buy
1,133
+158
+16% +$42.5K ﹤0.01% 2977
2015
Q4
$587K Buy
+975
New +$587K ﹤0.01% 2683